WO2001077150A3 - Serine-threonine kinase - Google Patents

Serine-threonine kinase Download PDF

Info

Publication number
WO2001077150A3
WO2001077150A3 PCT/EP2001/004036 EP0104036W WO0177150A3 WO 2001077150 A3 WO2001077150 A3 WO 2001077150A3 EP 0104036 W EP0104036 W EP 0104036W WO 0177150 A3 WO0177150 A3 WO 0177150A3
Authority
WO
WIPO (PCT)
Prior art keywords
serine
threonine kinase
polypeptides
stk3
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/004036
Other languages
French (fr)
Other versions
WO2001077150A2 (en
Inventor
Burkhard Scharm
Detlef Guessow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to EP01936211A priority Critical patent/EP1272641A2/en
Priority to JP2001575620A priority patent/JP2003530122A/en
Priority to CA002405730A priority patent/CA2405730A1/en
Priority to US10/257,143 priority patent/US20060058516A1/en
Publication of WO2001077150A2 publication Critical patent/WO2001077150A2/en
Publication of WO2001077150A3 publication Critical patent/WO2001077150A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

STK3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing STK3 polypeptides and polynucleotides in diagnostic assays.
PCT/EP2001/004036 2000-04-10 2001-04-09 Serine-threonine kinase Ceased WO2001077150A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01936211A EP1272641A2 (en) 2000-04-10 2001-04-09 Serine-threonine kinase
JP2001575620A JP2003530122A (en) 2000-04-10 2001-04-09 Novel serine-threonine kinase
CA002405730A CA2405730A1 (en) 2000-04-10 2001-04-09 Serine-threonine kinase
US10/257,143 US20060058516A1 (en) 2000-04-10 2001-04-09 Novel serine-threonine kinase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00107141.4 2000-04-10
EP00107141 2000-04-10

Publications (2)

Publication Number Publication Date
WO2001077150A2 WO2001077150A2 (en) 2001-10-18
WO2001077150A3 true WO2001077150A3 (en) 2002-03-28

Family

ID=8168352

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/004036 Ceased WO2001077150A2 (en) 2000-04-10 2001-04-09 Serine-threonine kinase

Country Status (5)

Country Link
US (1) US20060058516A1 (en)
EP (1) EP1272641A2 (en)
JP (1) JP2003530122A (en)
CA (1) CA2405730A1 (en)
WO (1) WO2001077150A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2464729A1 (en) * 2001-10-30 2003-05-08 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US20050244825A1 (en) * 2002-03-27 2005-11-03 Bayer Healthcare Ag Regulation of human bmp-2 inducible kinase
WO2003087394A1 (en) * 2002-04-15 2003-10-23 Glaxo Group Limited A method of identifying a modudator for a serine/theronine kinase
WO2007002088A2 (en) * 2005-06-20 2007-01-04 Exelixis, Inc. Psat1s as modifiers of the pten/akt pathway and methods of use

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058675A2 (en) * 1998-05-14 1999-11-18 Chiron Corporation Human genes and gene expression products v
WO2000021976A1 (en) * 1998-10-15 2000-04-20 The General Hospital Corporation Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods
WO2001002568A2 (en) * 1999-07-02 2001-01-11 Chiron Corporation Human genes and gene expression products
WO2001038503A2 (en) * 1999-11-24 2001-05-31 Sugen, Inc. Novel human protein kinases and protein kinase-like enzymes
EP1130094A2 (en) * 1999-07-08 2001-09-05 Helix Research Institute Primers for synthesizing full length cDNA clones and their use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058675A2 (en) * 1998-05-14 1999-11-18 Chiron Corporation Human genes and gene expression products v
WO2000021976A1 (en) * 1998-10-15 2000-04-20 The General Hospital Corporation Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods
WO2001002568A2 (en) * 1999-07-02 2001-01-11 Chiron Corporation Human genes and gene expression products
EP1130094A2 (en) * 1999-07-08 2001-09-05 Helix Research Institute Primers for synthesizing full length cDNA clones and their use
WO2001038503A2 (en) * 1999-11-24 2001-05-31 Sugen, Inc. Novel human protein kinases and protein kinase-like enzymes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 27 January 2000 (2000-01-27), KOEHRER K ET AL: "Hypothetical 73.8kD protein", XP002182061 *
DATABASE STRPEMBL 1 October 2000 (2000-10-01), "Hypothetical 73.8kD protein", XP002182062 *
See also references of EP1272641A2 *

Also Published As

Publication number Publication date
CA2405730A1 (en) 2001-10-18
WO2001077150A2 (en) 2001-10-18
JP2003530122A (en) 2003-10-14
EP1272641A2 (en) 2003-01-08
US20060058516A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
EP1001023A3 (en) Frizzled-4, a putative Wnt-receptor
WO2002090520A3 (en) Toll/interleukin-1 receptor adaptor protein (tirap)
EP0939124A3 (en) MGBP1 sequences
WO2001072961A3 (en) Novel compounds
WO2001004141A3 (en) Seripancrin
WO2001083768A3 (en) Serine-threonine kinase
WO1999035266A3 (en) Human urotensin ii
WO2001083744A3 (en) Natrium-calcium exchanger protein
WO2001085921A3 (en) Human serine-threonine kinase-4
WO2002004600A3 (en) Novel compounds
WO2002014355A3 (en) Novel mitogen activated kinase
WO2001085954A3 (en) Serine-threonine kinase-3
WO2002002780A3 (en) Human serine-threonine kinase
AU8394601A (en) A novel member of the epha receptor family
WO2001072963A3 (en) Novel human uridine kinase
WO2001068816A8 (en) Human histamine h3 gene variant-3
WO2001055428A3 (en) Mprot45 metalloprotease
EP0887416A3 (en) Human AFC1
WO2002032937A3 (en) Neuromedin u delta
WO2001055338A3 (en) 7tm receptor axor51
WO2001083771A3 (en) Human phospholipase c delta 5
WO2001062779A3 (en) New transcription factor carp-2
WO2001068703A8 (en) Human histamine h3 gene variant-2
EP0969091A3 (en) Leptin receptor gene-related protein
EP0887415A3 (en) Human RCE1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2001936211

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 575620

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2405730

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2006058516

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10257143

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001936211

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10257143

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001936211

Country of ref document: EP